Dr. Brigitte Simons is a c-suite executive in support of leading-edge cannabis product development, laboratory services, and data management tools for the development of safe cannabis accessed globally. Bridging expertise within chemistry, pharma drug development, and environmental testing – Brigitte has a professional track record for laboratory quality control business development, analytical service contracting excellence for the Canadian federal agencies, and global sales experience in high value trade of laboratory services. Dr. Simons has working experience within the Canadian Food Inspection, Health Canada, Agriculture Canada, and Environment Canada. She spent over 6 years working in the Drug Toxicology and Analysis Division at Health Canada in a laboratory setting to inform regulatory policy development for new drugs. She completed post-doctoral fellowship at the Clinical Sciences Hospital of the National Heart, Blood & Lung Institute within the famous NIH campus in Maryland, USA. Continuing in lab specialities, Brigitte then joined SCIEX, a global instrumentation vendor for hardware and software for mass spectrometry. With over 16 years experience with operating mass spectrometers, Brigitte managed Canadian federal and provincial government sales for full laboratory services, covering clinical, forensics to product health and environmental safety. Prior to working abroad, Brigitte received her Ph.D. in Chemical Biology at the University of Ottawa in a joint chemistry program with drug pharmacology at Health Canada. Brigitte is now the Chief Scientific Officer of Pasha Brands Ltd.